Lv616
1840 积分 2023-12-21 加入
Diabetic Foot Ulcers
2小时前
待确认
Antimicrobial peptides: An alternative to traditional antibiotics
2小时前
待确认
Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial
2天前
已完结
Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial
2天前
已完结
Pharmacokinetics and Safety of Spesolimab in Healthy Chinese Subjects: An Open-Label, Phase I Study
2天前
已完结
Cure as a treatment target in rheumatoid arthritis and systemic sclerosis—achievable aim or mission impossible? FOREUM stimulates new industry-academia collaboration
6天前
已完结
Correction: Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study
6天前
已完结
Risankizumab for Ulcerative Colitis
7天前
已完结
Risankizumab for Ulcerative Colitis—Reply
7天前
已完结
Destructive and Protective Effects and Therapeutic Targets of IL-36 Family Cytokines in Dry Eye Disease
7天前
已完结
皖公网安备34019202002308
